Pharmaceutical

Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Jan 29, 2024 - 18:00
Bristol Myers Squibb’s Abecma recommended for EU approval
The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.
Read the original article

Tags:

Previous Article

Celltrion USA seeks FDA approval for CT-P47 biosimilar

Next Article

‘Seismic shift’ to crowdsourced scientific data presents promising, complex oppo...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Intas Pharma employee used acid to destroy manufacturing records at troubled plant

STAT+: Intas Pharma employee used acid to destroy manuf...

Aug 1, 2023

New tool for tracing blood cells’ ancestry might one day help predict disease risk

New tool for tracing blood cells’ ancestry might one da...

Jan 22, 2024

Opinion: The next frontier in biomedicine: AI models of the human immune system

Opinion: The next frontier in biomedicine: AI models of...

Oct 6, 2023